Amylyx Pharmaceuticals, Inc.
Nasdaq · CIK 0001658551 · Fiscal year end 1231
Latest reported period: Latest published period
Recent financials
| Metric | Current | Prior | Change |
|---|
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 4 | Amylyx Pharmaceuticals, Inc. | 2026-07-13 | 0001193125-26-301996 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2026-05-26 | 0001193125-26-239216 |
| 10-Q | Amylyx Pharmaceuticals, Inc. | 2026-05-07 | 0001193125-26-210292 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2026-03-09 | 0001193125-26-098438 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2026-03-09 | 0001193125-26-098437 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2026-03-09 | 0001193125-26-098440 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2026-03-09 | 0001193125-26-098436 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2026-03-09 | 0001193125-26-098439 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2026-03-04 | 0001193125-26-091442 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2026-03-04 | 0001193125-26-091438 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2026-03-04 | 0001193125-26-091436 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2026-03-04 | 0001193125-26-091443 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2026-03-04 | 0001193125-26-091440 |
| 10-K | Amylyx Pharmaceuticals, Inc. | 2026-03-03 | 0001193125-26-086645 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2026-02-25 | 0001193125-26-071460 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2026-02-04 | 0001193125-26-037553 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2026-02-04 | 0001193125-26-037548 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2026-02-04 | 0001193125-26-037544 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2026-02-04 | 0001193125-26-037552 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2026-01-20 | 0001193125-26-017057 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2026-01-20 | 0001193125-26-017056 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2026-01-14 | 0001193125-26-012921 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2026-01-08 | 0001193125-26-007666 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2026-01-08 | 0001193125-26-007664 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2026-01-08 | 0001193125-26-007669 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2025-12-23 | 0001193125-25-331289 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2025-12-03 | 0001193125-25-306818 |
| 10-Q | Amylyx Pharmaceuticals, Inc. | 2025-11-06 | 0001193125-25-268059 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2025-10-02 | 0001193125-25-228342 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2025-10-02 | 0001193125-25-228341 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2025-10-02 | 0001193125-25-228340 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2025-10-02 | 0001193125-25-228339 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2025-10-02 | 0001193125-25-228343 |
| 4 | Amylyx Pharmaceuticals, Inc. | 2025-08-14 | 0000950170-25-108912 |
| 10-Q | Amylyx Pharmaceuticals, Inc. | 2025-08-07 | 0001193125-25-174948 |